Second, even though we revealed a parallel decrement of ALT and hepassocin in human subjects, further study on the serial changes of hepassocin to confirm its release pattern during the clinical course of hyperthyroidism will be needed. The gene discussed is FGL1; the disease is hyperthyroidism.